4//SEC Filing
ELAN PHARMACEUTICAL INVESTMENTS LTD 4
Accession 0000950162-04-000479
CIK 0000810084other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 2:13 PM ET
Size
9.9 KB
Accession
0000950162-04-000479
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-04-07$3.00/sh−7,500$22,500→ 2,442,436 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and by its wholly-owned subsidiary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subsidiary of Elan International Services, Ltd.
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeother
Related Parties
1- filerCIK 0001279105
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 2:13 PM ET
- Size
- 9.9 KB